Acetylcholinesterase Inhibitor Pyridostigmine Bromide Attenuates Gut Pathology and Bacterial Dysbiosis in a Murine Model of Ulcerative Colitis Article

Singh, Shashi P, Chand, Hitendra S, Banerjee, Santanu et al. (2020). Acetylcholinesterase Inhibitor Pyridostigmine Bromide Attenuates Gut Pathology and Bacterial Dysbiosis in a Murine Model of Ulcerative Colitis . DIGESTIVE DISEASES AND SCIENCES, 65(1), 141-149. 10.1007/s10620-019-05838-6

Open Access

cited authors

  • Singh, Shashi P; Chand, Hitendra S; Banerjee, Santanu; Agarwal, Hemant; Raizada, Veena; Roy, Sabita; Sopori, Mohan

sustainable development goals

authors

publication date

  • January 1, 2020

webpage

published in

keywords

  • Acetylcholine
  • BARRIER
  • Bacterial dysbiosis
  • CHOLINERGIC STIMULATION
  • CIGARETTE-SMOKE
  • CLOSTRIDIUM-DIFFICILE INFECTION
  • COLON
  • CROHNS-DISEASE
  • Dextran sodium sulfate
  • FECAL MICROBIOTA TRANSPLANTATION
  • GOBLET CELL
  • Gastroenterology & Hepatology
  • Life Sciences & Biomedicine
  • MUC2 MUCIN
  • Pyridostigmine bromide
  • RECEPTOR
  • Science & Technology
  • Ulcerative colitis

Digital Object Identifier (DOI)

publisher

  • SPRINGER

start page

  • 141

end page

  • 149

volume

  • 65

issue

  • 1